Literature DB >> 33169274

Before-after cohort study to assess the efficacy of fractional ablative carbon dioxide laser treatment of pediatric hand scars.

Huazhen Liu1, Shisheng Chen1, Xuwei Zhu1, Zifu Zhou1, Jin Zhang2, Haiting Xu3,4.   

Abstract

The purpose of this study is to investigate the efficacy of fractional ablative carbon dioxide laser (AFXL) surgery in patients with pediatric hand scars. This study enrolled hand scar patients who received treatment in our hospital between May 2018 and April 2019. Patients were assigned to undergo AFXL surgery based on their personal intents and condition, whereas the fractional laser was used for stiffness and abnormal texture. Outcomes were as follows: hand function was evaluated using the Michigan hand outcomes questionnaire; scar condition was evaluated using the Vancouver scar scale and UNC4P scar scale. Total 30 pediatric patients (mean age, 11.4 years) were eligible for the study and laser-treated scars were significantly improved in Michigan hand outcomes questionnaire from 52.30 ± 6.14 to 66.91 ± 6.43 (p < 0.001). Provider-rated Vancouver scar scale dropped from 8.80 ± 2.75 to 6.73 ± 2.52 (p < 0.001). Patient-reported UNC4P scar scale declined from7.07 ± 2.02 to 4.73 ± 1.31 (p < 0.001). AFXL surgery can significantly improve hand function and appearance of pediatric hand scars, suggesting its advantages over traditional methods of operative intervention.
© 2020. Springer-Verlag London Ltd., part of Springer Nature.

Entities:  

Keywords:  Fractional carbon dioxide laser; Hand function; Hand scar; Pediatric patients

Year:  2020        PMID: 33169274     DOI: 10.1007/s10103-020-03186-w

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  11 in total

1.  Visible vs hidden scars and their relation to body esteem.

Authors:  John W Lawrence; James A Fauerbach; Leslie Heinberg; Marion Doctor
Journal:  J Burn Care Rehabil       Date:  2004 Jan-Feb

Review 2.  The use of corticosteroids to treat keloids: a review.

Authors:  Claude Roques; Luc Téot
Journal:  Int J Low Extrem Wounds       Date:  2008-07-08       Impact factor: 2.057

3.  Return of hand function following major burns.

Authors:  M H Covey; K Dutcher; D M Heimbach; J A Marvin; L H Engrav; B deLateur
Journal:  J Burn Care Rehabil       Date:  1987 May-Jun

4.  In-Vivo Histological Analysis of a Fractional CO2 Laser System Intended for Treatment of Soft Tissue.

Authors:  Elisabeth Hurliman; Brian Zelickson; Jeffrey Kenkel
Journal:  J Drugs Dermatol       Date:  2017-11-01       Impact factor: 2.114

5.  The 5-D itch scale: a new measure of pruritus.

Authors:  S Elman; L S Hynan; V Gabriel; M J Mayo
Journal:  Br J Dermatol       Date:  2009-12-01       Impact factor: 9.302

6.  Fractional CO2 laser treatment of caesarean section scars-A randomized controlled split-scar trial with long term follow-up assessment.

Authors:  Katrine E Karmisholt; Elisabeth H Taudorf; Camilla B Wulff; Emily Wenande; Peter A Philipsen; Merete Haedersdal
Journal:  Lasers Surg Med       Date:  2016-11-08       Impact factor: 4.025

7.  Appropriate timing for thyroidectomy scar treatment using a 1,550-nm fractional erbium-glass laser.

Authors:  Kui Young Park; In Young Oh; Seong Jun Seo; Kyung Ho Kang; Sung Jun Park
Journal:  Dermatol Surg       Date:  2013-11-07       Impact factor: 3.398

8.  Long-term functional results of selective treatment of hand burns.

Authors:  W Frist; F Ackroyd; J Burke; C Bondoc
Journal:  Am J Surg       Date:  1985-04       Impact factor: 2.565

9.  Skin characteristics after fractional photothermolysis.

Authors:  Byung Ho Oh; Young Ji Hwang; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

10.  Costs and outcome for serious hand and arm injuries during the first year after trauma - a prospective study.

Authors:  Hans-Eric Rosberg; Katarina Steen Carlsson; Ragnhild I Cederlund; Eva Ramel; Lars B Dahlin
Journal:  BMC Public Health       Date:  2013-05-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.